Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events.
Grayston
J T
JT
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000097:blood; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002690:Chlamydia Infections / Q000188:drug therapy*; D016993:Chlamydophila pneumoniae / Q000276:immunology; D006801:Humans
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial